Evidence map›Paper›PMID 39590223›Full record

ArticleBiomimetics (Basel, Switzerland)2024

Enhanced Mechanical Properties and Degradation Control of Poly(Lactic) Acid/Hydroxyapatite/Reduced Graphene Oxide Composites for Advanced Bone Tissue Engineering Application.

Francis T Omigbodun, Bankole I Oladapo

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francis T OmigbodunWolfson School of Mechanical, Electrical and Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, UK.ORCID 0000-0002-9745-5655
Bankole I OladapoSchool of Science and Engineering, University of Dundee, Dundee DD1 4HN, UK.ORCID 0000-0003-1731-9117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the enhancement of poly(lactic acid) (PLA) matrix using calcium hydroxyapatite (cHAP) and reduced graphene oxide (rGO) for developing composite scaffolds aimed at bone regeneration applications. The PLA composites were fabricated through solvent evaporation and melt extrusion and characterized by various techniques, including thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and mechanical testing. The incorporation of cHAP and rGO significantly improved the thermal, mechanical, and morphological properties of the PLA matrix. Mechanical testing revealed that adding 10% cHAP and varying amounts of rGO (0.1%, 0.3%, 0.5%) enhanced tensile and compressive strengths, with the highest improvements observed at 0.5% rGO content. Thermal analysis showed increased thermal stability with higher degradation temperatures for the composites. Spectroscopic analyses confirmed the effective integration of cHAP and rGO into the PLA matrix with characteristic peaks of the fillers identified in the composite spectra. In vitro, degraded action tests in phosphate-buffered saline (PBS) at pH 7.4 over 12 months indicated that composites with higher rGO content exhibited lower mass loss and better mechanical stability. Furthermore, finite element analysis (FEA) simulations were performed to validate the experimental results, demonstrating a strong correlation between simulated and experimental compressive strengths. This novel approach demonstrates the potential of PLA/cHAP/rGO composites in creating effective and biocompatible scaffolds for tissue engineering, providing a comprehensive analysis of the synergistic effects of cHAP and rGO on the PLA matrix and offering a promising material for bone regeneration applications.

Indexed as

additive manufacturingbiodegradable compositesbone tissue engineeringcomposite scaffoldsnanocompositestissue regeneration

Identifiers

PMID39590223
PMCPMC11592037

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.